| Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the … DS Baldwin, IM Anderson, DJ Nutt, C Allgulander, B Bandelow, ... Journal of Psychopharmacology 28 (5), 403-439, 2014 | 915 | 2014 |
| Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition B Bandelow, D Baldwin, M Abelli, B Bolea-Alamanac, M Bourin, ... The World Journal of Biological Psychiatry 18 (3), 162-214, 2017 | 451 | 2017 |
| Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline K Pottie, W Thompson, S Davies, J Grenier, CA Sadowski, V Welch, ... Canadian Family Physician 64 (5), 339-351, 2018 | 415 | 2018 |
| Benzodiazepines: risks and benefits. A reconsideration DS Baldwin, K Aitchison, A Bateson, HV Curran, S Davies, B Leonard, ... Journal of psychopharmacology 27 (11), 967-971, 2013 | 375 | 2013 |
| Antidepressant-induced jitteriness/anxiety syndrome: systematic review LI Sinclair, DM Christmas, SD Hood, JP Potokar, A Robertson, A Isaac, ... The British Journal of Psychiatry 194 (6), 483-490, 2009 | 228 | 2009 |
| Association of panic disorder and panic attacks with hypertension SJC Davies, P Ghahramani, PR Jackson, TW Noble, PG Hardy, ... The American journal of medicine 107 (4), 310-316, 1999 | 194 | 1999 |
| Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia SJC Davies, AM Burhan, D Kim, P Gerretsen, A Graff-Guerrero, VL Woo, ... Journal of Psychopharmacology 32 (5), 509-523, 2018 | 168 | 2018 |
| Agomelatine versus other antidepressive agents for major depression G Guaiana, S Gupta, D Chiodo, SJC Davies, K Haederle, M Koesters Cochrane Database of Systematic Reviews, 2013 | 168 | 2013 |
| Is there cognitive impairment in clinically ‘healthy’abstinent alcohol dependence? SJC Davies, SA Pandit, A Feeney, BJ Stevenson, RW Kerwin, DJ Nutt, ... Alcohol and alcoholism 40 (6), 498-503, 2005 | 164 | 2005 |
| A biological pathway linking inflammation and depression: activation of indoleamine 2, 3-dioxygenase DM Christmas, JP Potokar, SJC Davies Neuropsychiatric disease and treatment, 431-439, 2011 | 157 | 2011 |
| Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews S Ijaz, B Bolea, S Davies, J Savović, A Richards, S Sullivan, P Moran BMC psychiatry 18 (1), 275, 2018 | 127 | 2018 |
| Treatment of anxiety and depressive disorders in patients with cardiovascular disease SJC Davies, PR Jackson, J Potokar, DJ Nutt Bmj 328 (7445), 939-943, 2004 | 119 | 2004 |
| Antidepressants versus placebo for panic disorder in adults (protocol only) G Guaiana, C Barbui, D Chiodo, A Cipriani, S Davies, M Koesters Cochrane Database of Systematic Reviews, 2013 | 104* | 2013 |
| Benzodiazepines versus placebo for panic disorder in adults J Breilmann, F Girlanda, G Guaiana, C Barbui, A Cipriani, M Castellazzi, ... Cochrane database of systematic reviews, 2019 | 94 | 2019 |
| Prediction of Working Memory Performance in Schizophrenia by Plasma Ratio of Clozapine to N-Desmethylclozapine TK Rajji, BH Mulsant, S Davies, SM Kalache, C Tsoutsoulas, BG Pollock, ... American Journal of Psychiatry 172 (6), 579-585, 2015 | 93 | 2015 |
| Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards SJC Davies, S Eayrs, P Pratt, MS Lennard British journal of clinical pharmacology 57 (4), 464-472, 2004 | 92 | 2004 |
| Addiction AR Lingford-Hughes, SJC Davies, S Mclver, TM Williams, M Daglish, ... British Medical Bulletin 65, 209-222, 2003 | 87 | 2003 |
| Panic disorder and subthreshold panic in the UK general population: epidemiology, comorbidity and functional limitation P Skapinakis, G Lewis, S Davies, T Brugha, M Prince, N Singleton European Psychiatry 26 (6), 354-362, 2011 | 86 | 2011 |
| Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR) DS Kessler, SJ MacNeill, D Tallon, G Lewis, TJ Peters, W Hollingworth, ... bmj 363, 2018 | 85 | 2018 |
| Panic disorder, anxiety and depression in resistant hypertension-a case–control study SJC Davies, P Ghahramani, PR Jackson, J Hippisley-Cox, WW Yeo, ... Journal of hypertension 15 (10), 1077-1082, 1997 | 85 | 1997 |
David NuttProfessor of Neuropharmacology Imperial College LondonVerified email at imperial.ac.uk
